参考文献
[1] C.W. Tsao, A.W. Aday, Z.I. Almarzooq, A. Alonso, A.Z. Beaton, et al., Heart disease and stroke statistics-2022 update: a report from the American heart association, Circulation 145 (2022) e153–e639, https://doi.org/10.1161/ CIR.0000000000001052.
[2] F. Crea, I. Battipaglia, F. Andreotti, Sex differences in mechanisms, presentation and management of ischaemic heart disease, Atherosclerosis 241 (1) (2015 Jul) 157–168,
[3] P. Libby, J.E. Buring, L. Badimon, G.K. Hansson, J. Deanfield, et al., Atherosclerosis. Nat Rev Dis Primers. 5 (1) (2019 Aug 16) 56, https://doi.org/ 10.1038/s41572-019-0106-z.
[4] R. Mehran, B. Vogel, R. Ortega, R. Cooney, R. Horton, The Lancet Commission on women and cardiovascular disease: time for a shift in women’s health, Lancet 393 (10175) (2019 Mar 9) 967–968, https://doi.org/10.1016/S0140-6736(19) 30315-0.
[5] M.I. Ghare, J. Chandrasekhar, R. Mehran, V. Ng, C. Grines, et al., Sex disparities in cardiovascular device evaluations: strategies for recruitment and retention of female patients in clinical device trials, JACC Cardiovasc. Interv. 12 (2019) 301–308. Arora S, Stouffer GA, Kucharska-Newton AM, Qamar A, Vaduganathan M, Pandey A, Porterfield D, Blankstein R, Rosamond WD, Bhatt DL, Caughey MC. Twenty year trends and sex differences in young adults hospitalized with acute myocardialinfarction. Circulation 2019;139:1047–1056. doi: 10.1016/j. cin.2018.10.048.
[6] E. Cenko, J. Yoon, S. Kedev, G. Stankovic, Z. Vasiljevic, et al., Sex differences in outcomes after STEMI: effect modification by treatment strategy and age, JAMA Intern. Med. 178 (5) (2018 May 1) 632–639,
[7] Canadian Institutes of Health Research Institute of Gender and Health, Definitions of Sex and Gender, 2015.
[8] G.M. Rubanyi, K. Kauser, A. Johns, Role of estrogen receptors in the vascular system, Vasc. Pharmacol. 38 (2002) 81–88, https://doi.org/10.1016/s0306-3623 (02)00130-1.
[9] M. Barton, Cholesterol and atherosclerosis: modulation by oestrogen, Curr. Opin. Lipidol. 24 (3) (2013 Jun) 214–220,
[10] G. Catalano, E. Duchene, Z. Julia, W. Le Goff, E. Bruckert, et al., Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjects, J. Lipid Res. 49 (3) (2008 Mar) 635–643, https://doi.org/10.1194/jlr.M700510- JLR200.
[11] C.G. Santos-Gallego, B. Ibanez, J.J. Badimon, HDL-cholesterol: is it really good? Differences between apoA-I and HDL, Biochem. Pharmacol. 76 (4) (2008 Aug 15) 443–452,
[12] H.K. Riise, G. Sulo, G.S. Tell, J. Igland, O. Nygard, et al., Incident coronary heart disease after preeclampsia: role of reduced fetal growth, preterm delivery, and parity, J. Am. Heart Assoc. 6 (2017), e004158, https://doi.org/10.1161/ JAHA.116.004158. [13] A.R. Markovitz, J.J. Stuart, J. Horn, P.L. Williams, E.B. Rimm, et al., Does pregnancy complication history improve cardio- vascular disease risk prediction? Findings from the HUNT study in Norway, Eur. Heart J. 40 (2019) 1113–1120,
[14] F.L.J. Visseren, F. Mach, Y.M. Smulders, D. Carballo, K.C. Koskinas, et al., ESC National cardiac societies; ESC scientific document group. 2021 ESC guidelines on cardiovascular disease prevention in clinical practice, Eur. Heart J. 42 (34) (2021 Sep 7) 3227–3337,
[15] B.R. England, G.M. Thiele, D.R. Anderson, T.R. Mikuls, Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications, BMJ 361 (2018 Apr 23) k1036, https://doi.org/10.1136/bmj.k1036.
[16] T.H. Collet, J. Gussekloo, D.C. Bauer, W.P. den Elzen, A.R. Cappola, et al., Thyroid Studies Collaboration. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality, Arch. Intern. Med. 172 (2012) 799–809,
[17] T.R. Berni, C.L. Morgan, D.A. Rees, Women with polycystic ovary syndrome have an increased risk of major cardiovascular events: a population study, J. Clin. Endocrinol. Metab. 106 (9) (2021 Aug 18) e3369–e3380
[18] I. Njolstad, E. Arnesen, P.G. Lund-Larsen, Smoking, serum lipids, blood pressure, and sex differences in myocardial infarction. A 12-year follow-up of the Finnmark Study, Circulation 93 (1996) 450–456, https://doi.org/10.1161/01.cir.93.3.450. [19] E. Solinas, L. Vignali, P. Ortolani, P. Guastaroba, A. Marzocchi, et al., Association of bleeding, mortality and sex in acute coronary syndromes: the missing triangle, J. Cardiovasc. Med. 16 (5) (2015 May) 347–354
[20] C.G. Santos-Gallego, J. Bayon, ´ J.J. Badimon, ´ Thrombi of different pathologies: implications for diagnosis and treatment, Curr. Treat. Options Cardiovasc. Med. 12 (3) (2010 Jun) 274–291, https://doi.org/10.1007/s11936-010-0075-8.
[21] J.R. Coleman, E.E. Moore, M.R. Kelher, J.M. Samuels, M.J. Cohen, et al., Female platelets have distinct functional activity compared with male platelets: implications in transfusion practice and treatment of trauma-induced coagulopathy, J. Trauma Acute Care Surg. 87 (5) (2019 Nov) 1052–1060, https:// doi.org/10.1097/TA.0000000000002398.
[20] S.C. Rodgers, K.T. Carter, D. Patki, R.C. O’Brien, M.E. Kutcher, Thromboelastography-based evaluation of gender-associated hypercoagulability, Am. Surg. 88 (11) (2022 Nov) 2619–2625
[23] T. Padro, N. Munoz-Garcia, ˜ E. Pena, ˜ L. Badimon, Sex differences and emerging new risk factors for atherosclerosis and its thrombotic complications, Curr. Pharmaceut. Des. 27 (29) (2021 Sep 23) 3186–3197, https://doi.org/10.2174/ 1381612826666201118094209.
[24] World Health Organization, Depression and other common mental disorders: global health estimates, Available from: https://apps.who.int/iris/bitstream/h andle/10665/254610/WHO- MSD- MER- 2017.2- eng.pdf?sequence=1, 2018.
[25] V.V. Gafarov, D.O. Panov, E.A. Gromova, I.V. Gagulin, A.V. Gafarova, The influence of depression on risk development of acute cardiovascular diseases inthe female population aged 25-64 in Russia, Int. J. Circumpolar Health 72 (5 Aug. 2013),
[26] K.K. Larsen, Depression following myocardial infarction–an overseen complication with prognostic importance, Dan. Med. J. 60 (8) (2013 Aug), B4689.
[27] W. de Vente, J.G. van Amsterdam, M. Olff, J.H. Kamphuis, P.M. Emmelkamp, Burnout is associated with reduced parasympathetic activity and reduced HPA Axis responsiveness, predominantly in males, BioMed Res. Int. 2015 (2015), 431725, https://doi.org/10.1155/2015/431725. Epub 2015 Oct 18.
[28] C. Wang, F. Lˆe-Scherban, J. Taylor, E. Salmoirago-Blotcher, M. Allison, et al., Associations of job strain, stressful life events and social strain with coronary heart disease in the Women’s Health Initiative Observational Study, J. Am. Heart Assoc. 10 (2021), e017780
[29] A.M. Roest, E.J. Martens, P. de Jonge, J. Denollet, Anxiety and risk of incident coronary heart disease: a meta-analysis, J. Am. Coll. Cardiol. 56 (2010) 38–46, https://doi.org/10.1016/j.jacc.2010.03.034.
[30] MU Zafar, M Paz-Yepes, D Shimbo, G Vilahur, MM Burg, C, et al., Anxiety is a better predictor of platelet reactivity in coronary artery disease patients than depression, Eur Heart J. 31 (13) (2010 Jul) 1573–1582.
[31] E.N. Wright, A. Hanlon, A. Lozano, A.M. Teitelman, The impact of intimate partner violence, depressive symptoms, alcohol dependence, and perceived stress on 30-year cardiovascular disease risk among young adult women: a multiple mediation analysis, Prev. Med. 121 (2019) 47–54, https://doi.org/10.1016/j. ypmed.2019.01.016.
[32] A. Rosengren, A. Smyth, S. Rangarajan, C. Ramasundarahettige, S.I. Bangdiwala, et al., Socioeconomic status and risk of cardiovascular disease in 20 low-income, middle-income, and high-income countries: the Prospective Urban Rural Epidemiologic (PURE) study, Lancet Global Health 7 (2019) e748–e760, https:// doi.org/10.1016/S2214-109x(19)30045-2.
[33] D.C. Eindhoven, A.D. Hilt, T.C. Zwaan, M.J. Schalij, C.J.W. Borleffs, Age and gender differences in medical adherence after myocardial infarction: women do not receive optimal treatment - The Netherlands claims database, Eur J Prev Cardiol 25 (2) (2018 Jan) 181–189, https://doi.org/10.1177/ 2047487317744363. Epub 2017 Nov 22.
[34] A. Rossi, N. Mikail, S. Bengs, A. Haider, V. Treyer, et al., Heart-brain interactions in cardiac and brain diseases: why sex matters, Eur. Heart J. (2022 Feb 23), ehac061,
[35] A. Haider, S. Bengs, F. Diggelmann, G. Epprecht, D. Etter, et al., Age- and sexdependent changes of resting amygdalar activity in individuals free of clinical cardiovascular disease, J. Nucl. Cardiol. 28 (2021) 427–432, https://doi.org/ 10.1007/s12350-020-02504-7.
[36] D.O. Kang, J.S. Eo, E.J. Park, H.S. Nam, J.W. Song, et al., Stress-associated neurobiological activity is linked with acute plaque instability via enhanced macro- phage activity: a prospective serial 18F-FDG-PET/CT imaging assessment, Eur. Heart J. 42 (2021) 1883–1895, https://doi.org/10.1093/eurheart/ ehaa1095.
[37] P.K. Mehta, J. Huang, R.D. Levit, W. Malas, N. Waheed, et al., Ischemia and no obstructive coronary arteries (INOCA): a narrative review, Atherosclerosis 363 (2022 Dec) 8–21
[38] G. Scalone, G. Niccoli, F. Crea, Editor’s Choice- Pathophysiology, diagnosis and management of MINOCA: an update, Eur. Heart J.Acute Cardiovasc. Care 8 (1) (2019 Feb) 54–62, https://doi.org/10.1177/2048872618782414. Epub 2018 Jun 28.
[39] L. Jespersen, A. Hvelplund, S.Z. Abildstrøm, F. Pedersen, S. Galatius, et al., Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events, Eur. Heart J. 33 (6) (2012 Mar) 734–744, https://doi.org/10.1093/eurheartj/ehr331. Epub 2011 Sep. 11.
[40] B. Sharaf, T. Wood, L. Shaw, B.D. Johnson, S. Kelsey, et al., Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation (WISE) angiographic core laboratory, Am. Heart J. 166 (1) (2013 Jul) 134–141, https:// doi.org/10.1016/j.ahj.2013.04.002. Epub 2013 May 2.
[41] H.R. Reynolds, A. Maehara, R.Y. Kwong, T. Sedlak, J. Saw, et al., Coronary optical coherence tomography and cardiac magnetic resonance imaging to determine underlying causes of myocardial infarction with nonobstructive coronary arteries in women, Circulation 143 (7) (2021 Feb 16) 624–640,
[42] R. Pelletier, J. Choi, N. Winters, M.J. Eisenberg, S.L. Bacon, et al., GENESISPRAXY investigators. Sex differences in clinical outcomes after premature acute coronary syndrome, Can. J. Cardiol. 32 (12) (2016 Dec) 1447–1453, https://doi. org/10.1016/j.cjca.2016.05.018.
[43] R. Puri, S.E. Nissen, M. Shao, C.M. Ballantyne, P.J. Barter, et al., Sex-related differences of coronary atherosclerosis regression following maximally intensive statin therapy: insights from SATURN, J. Am. Coll. Cardiol. Img. 7 (2014) 1013–1022.
